CCA
ELV icon

Carrera Capital Advisors’s Elevance Health ELV Stock Holding History

Carrera Capital Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-525
Closed -$228K – 155
2025
Q1 		$228K Sell
525
-313
-37% -$126K 0.05% 140
2024
Q4 		$309K Sell
838
-3,478
-81% -$1.46M 0.07% 114
2024
Q3 		$2.24M Buy
4,316
+528
+14% +$282K 0.55% 36
2024
Q2 		$2.05M Buy
+3,788
New +$2M 0.67% 25

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Carrera Capital Advisors's ELV Position: Q2 2025 in Review

Carrera Capital Advisors sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 525 shares — an estimated $228K sold.

Carrera Capital Advisors first reported a position in ELV in Q2 2024 and held it in 4 quarters. The position peaked at $2.24M in Q3 2024. 1,593 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Carrera Capital Advisors reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Carrera Capital Advisors sold 525 Elevance Health shares in Q2 2025, an estimated $228K.
  • Carrera Capital Advisors first reported a position in Elevance Health in Q2 2024 and held it in 4 quarters.
  • Carrera Capital Advisors's Elevance Health position peaked at $2.24M in Q3 2024.
  • 1,593 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Carrera Capital Advisors's 13F filing for Q2 2025, filed 31 Jul 2025.